About the Authors
- Natasja Nielsen
-
Affiliations Translational Immunology, Novo Nordisk A/S, Måløv, Denmark, Department of Microbiology and Immunology and the Cancer Research Institute, University of California San Francisco, San Francisco, California, United States of America
- Niels Ødum
-
Affiliation Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen, Denmark
- Birgitte Ursø
-
Affiliation Monocyte Biology, Inflammation Biology, Novo Nordisk A/S, Måløv, Denmark
- Lewis L. Lanier
-
Affiliation Department of Microbiology and Immunology and the Cancer Research Institute, University of California San Francisco, San Francisco, California, United States of America
- Pieter Spee
-
* E-mail: spee@novonordisk.com
Affiliation Translational Immunology, Novo Nordisk A/S, Måløv, Denmark
Competing Interests
NN, BU, and PS are employees of Novo Nordisk A/S and own shares. This project was partly supported by Novo Nordisk A/S. PS has assigned patents related to NKG2A and NNC0141-0100 (WO2007042573, 20070726; WO2007147898, 20071227; WO2008009545, 20080124; WO2009092805, 20090730). BU has a patent related to NKG2D (WO09077483, 20090625). LLL and UCSF have licensed intellectual property rights regarding NKG2D for commercial applications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NN PS. Performed the experiments: NN. Analyzed the data: NN. Contributed reagents/materials/analysis tools: LLL N BU. Wrote the paper: NN. Supervised research: LLL PS NØ. Edited the paper: LLL PS NØ. Facilitated the study: BU.